Arix Bioscience Aktie
WKN DE: A2DL9L / ISIN: GB00BD045071
Nachrichten zu Arix Bioscience PLC Registered Shs
| 12.02.24 | Scheme Effective (EQS Group) | |
| 12.02.24 | Suspension of Trading in Shares (EQS Group) | |
| 07.02.24 | Transaction Update (EQS Group) | |
| 29.01.24 | Results of First General Meeting (EQS Group) | |
| 24.01.24 | Holding(s) in Company (EQS Group) | |
| 24.01.24 | Holding(s) in Company (EQS Group) | |
| 23.01.24 | ||
| 22.01.24 | ||
| 19.01.24 | ||
| 19.01.24 | Unaudited NAV for December 2023 (EQS Group) | |
| 08.01.24 | ||
| 05.01.24 | Publication of Circular and RTW Bio Prospectus (EQS Group) | |
| 04.01.24 | Holding(s) in Company (EQS Group) | |
| 22.12.23 | ||
| 13.12.23 | Unaudited NAV for November 2023 (EQS Group) | |
| 08.12.23 | ||
| 13.11.23 | ||
| 10.11.23 | ||
| 10.11.23 | PDMR Notification & Director Shareholding  (EQS Group) | |
| 08.11.23 | Unaudited NAV for October 2023 (EQS Group) | |
| 03.11.23 | PDMR Notification & Director Shareholding  (EQS Group) | |
| 02.11.23 | PDMR Notification & Director Shareholding  (EQS Group) | |
| 01.11.23 | 
 
									 
									 
								